|
GTF2H2C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.04569949658185E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.95399996183454E-09 |
| Normal-vs-Stage2 |
6.90340000053524E-07 |
| Normal-vs-Stage3 |
2.80610001901493E-09 |
| Normal-vs-Stage4 |
5.1592063954331E-12 |
| Stage1-vs-Stage2 |
6.632800E-01 |
| Stage1-vs-Stage3 |
6.589400E-01 |
| Stage1-vs-Stage4 |
5.957300E-03 |
| Stage2-vs-Stage3 |
5.361600E-01 |
| Stage2-vs-Stage4 |
1.280220E-02 |
| Stage3-vs-Stage4 |
4.578500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.54600049113208E-10 |
| Normal-vs-AfricanAmerican |
1.459040E-03 |
| Normal-vs-Asian |
4.16220391485922E-11 |
| Caucasian-vs-AfricanAmerican |
1.869840E-01 |
| Caucasian-vs-Asian |
8.497700E-02 |
| AfricanAmerican-vs-Asian |
1.956330E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.58435503500232E-12 |
| Normal-vs-Female |
1.60710000862707E-09 |
| Male-vs-Female |
2.332800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.2620000317275E-09 |
| Normal-vs-Age(41-60Yrs) |
1.3944401189292E-13 |
| Normal-vs-Age(61-80Yrs) |
2.61579999882855E-08 |
| Normal-vs-Age(81-100Yrs) |
3.634800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.511800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.663400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.550600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.420800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.795000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.008800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.900400E-02 |
| Classical-VS-Follicular |
4.079500E-02 |
| Classical-VS-Other |
3.130600E-01 |
| Classical-VS-Normal |
1.36480005075157E-09 |
| Tall-VS-Follicular |
2.216300E-03 |
| Tall-VS-Other |
8.240400E-01 |
| Tall-VS-Normal |
9.93050086606218E-11 |
| Follicular-VS-Other |
1.386970E-01 |
| Follicular-VS-Normal |
1.25559999997193E-06 |
| Other-VS-Normal |
9.609300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.64460001172984E-10 |
| Normal-vs-N1 |
1.64509994515782E-09 |
| N0-vs-N1 |
1.209770E-01 |
|
|
